← All organizations

Iterum Therapeutics

For profitContributed to NMEWebsite ↗

Also known as: ITERUM THERAP | Iterum Therapeutics | Iterum Therapeutics, International Limited | Iterum Therapeutics, US Limited

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

First marketed drug

First NDA

Last known activity

Oct 25, 2024

Timeline

2010s

Jan 1, 2015
Iterum Therapeutics— Founded

2020s

Oct 25, 2024
procaine benzylpenicillin— NDA Secondary Org
Oct 25, 2024
sulopenem etzadroxil— NDA Organization

Drugs by trial phase (9 distinct, 8 trials)

Phase 4 (1 own, 0 via acquisition)

ciprofloxacin

Phase 3 (8 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (3)

Recent trials (11)

NCT04682834Lead sponsorN/A—
NCT05584657Study directorPhase 3Oct 18, 2022
NCT05584657Lead sponsorPhase 3Oct 18, 2022
NCT05026801Lead sponsorPhase 3Feb 8, 2021
NCT05026801Overall official - principal investigatorPhase 3Feb 8, 2021
NCT04700787Lead sponsorPhase 1Jan 21, 2021
NCT03357614Lead sponsorPhase 3Sep 18, 2018
NCT03358576Lead sponsorPhase 3Sep 18, 2018
NCT03354598Lead sponsorPhase 3Aug 1, 2018
NCT03366207Lead sponsorPhase 4Dec 15, 2017
NCT03366207Overall official - principal investigatorPhase 4Dec 15, 2017

Details

Founded: Dublin, IE Jan 1, 2015
First NDA: Oct 25, 2024
Last known activity: Oct 25, 2024